» Articles » PMID: 39911434

Unveiling the Prenatal Features of HADDS: A Case Report and Literature Review

Overview
Journal Heliyon
Date 2025 Feb 6
PMID 39911434
Authors
Affiliations
Soon will be listed here.
Abstract

Hypotonia, Ataxia, and Delayed Development Syndrome (HADDS), triggered by EBF3 mutations, is a neurodevelopmental disorder syndrome characterized by hypotonia, ataxia, and developmental delay. The affected individuals often are unable to care for themselves, which has a significant impact on society and families. Hence, prenatal screening and diagnosis are particularly important. However, symptoms and signs of HADDS caused by mutations in EBF3 have not been studied until now. Herein, we report the case of a 1-year-old boy carrying a heterozygous point mutation in the EBF3 gene (c.271 del, p. Asp91Thrfs∗41), who had typical signs and symptoms of mental retardation, hypotonia, developmental delay, neurogenic bladder, constipation, and Pectus excavatum, in addition to atypical facial features. HADDS was diagnosed by Whole Exome Sequencing on a family trio (Trio-WES) for recurrent urinary tract infection with dysuria at 6 months of age, with a normal karyotype and chromosomal microarray analysis (CMA). The variant is a shifted code mutation, which expands the pathogenic gene spectrum of EBF3. Furthermore, we did a retrospective analysis of HADDS patients with a history of pregnancy and childbirth. We emphasized that reduced fetal movement, systematic ultrasound scanning, and fetal MRI might add evidence for prenatal diagnosis. The study is the first to explore prenatal screening for this EBF3 gene-related HADDS and is of great relevance.

References
1.
Lopes F, Soares G, Goncalves-Rocha M, Pinto-Basto J, Maciel P . Whole Gene Deletion of Supporting Haploinsufficiency of This Gene as a Mechanism of Neurodevelopmental Disease. Front Genet. 2017; 8:143. PMC: 5640723. DOI: 10.3389/fgene.2017.00143. View

2.
Chao H, Davids M, Burke E, Pappas J, Rosenfeld J, McCarty A . A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3. Am J Hum Genet. 2016; 100(1):128-137. PMC: 5223093. DOI: 10.1016/j.ajhg.2016.11.018. View

3.
Thuret S, Bhatt L, OLeary D, Simon H . Identification and developmental analysis of genes expressed by dopaminergic neurons of the substantia nigra pars compacta. Mol Cell Neurosci. 2004; 25(3):394-405. DOI: 10.1016/j.mcn.2003.11.004. View

4.
Pruccoli J, Graziano C, Locatelli C, Maltoni L, Sheikh Maye H, Cordelli D . Expanding the Neurological Phenotype of Ring Chromosome 10 Syndrome: A Case Report and Review of the Literature. Genes (Basel). 2021; 12(10). PMC: 8535287. DOI: 10.3390/genes12101513. View

5.
Sleven H, Welsh S, Yu J, Churchill M, Wright C, Henderson A . De Novo Mutations in EBF3 Cause a Neurodevelopmental Syndrome. Am J Hum Genet. 2016; 100(1):138-150. PMC: 5223060. DOI: 10.1016/j.ajhg.2016.11.020. View